Results 11 to 20 of about 1,254,005 (293)

Aujeszky’s Disease and the Development of the Marker/DIVA Vaccination Concept [PDF]

open access: yesPathogens, 2020
Aujeszky’s disease or pseudorabies is an infection of animals caused by Suid alphaherpesvirus 1, also designated as pseudorabies virus (PrV). Whereas many mammals are susceptible to PrV, only pigs are able to survive productive infection.
Thomas C. Mettenleiter
doaj   +3 more sources

Oral rotavirus vaccine shedding as a marker of mucosal immunity [PDF]

open access: yesScientific Reports, 2021
Group A rotaviruses (RVA) remain a leading cause of pediatric diarrhea worldwide, in part due to underperformance of currently approved live-attenuated, oral vaccines in low-and-middle income countries.
Benjamin Lee   +12 more
doaj   +4 more sources

Infectious Bovine Rhinotracheitis Control Program in Slovakia

open access: yesFrontiers in Veterinary Science, 2021
As for other European countries, IBR is a significant cause of financial losses in cattle in Slovakia. The State Veterinary and Food Administration of the Slovak Republic prepared a voluntary IBR control program for cattle farms in 1995, which was ...
Rene Mandelik   +4 more
doaj   +1 more source

Predictive Markers of Immunogenicity and Efficacy for Human Vaccines [PDF]

open access: yesVaccines, 2021
Vaccines represent one of the major advances of modern medicine. Despite the many successes of vaccination, continuous efforts to design new vaccines are needed to fight “old” pandemics, such as tuberculosis and malaria, as well as emerging pathogens, such as Zika virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
van Tilbeurgh, Matthieu   +10 more
openaire   +4 more sources

Research Progress in Classical Swine Fever Virus Detection and Classical Swine Fever Vaccines

open access: yesGuangdong nongye kexue, 2022
Classical Swine Fever (CSF) is a highly infectious and fatal disease caused by Classical Swine Fever Virus (CSFV). It is recognized as one of the most serious viral diseases in pig industry.
Pu ZHANG   +7 more
doaj   +1 more source

The FlagT4G Vaccine Confers a Strong and Regulated Immunity and Early Virological Protection against Classical Swine Fever

open access: yesViruses, 2022
Control of classical swine fever virus (CSFV) in endemic countries relies on vaccination, mostly using vaccines that do not allow for differentiation of vaccinated from infected animals (DIVA).
José Alejandro Bohórquez   +8 more
doaj   +1 more source

The Development of Classical Swine Fever Marker Vaccines in Recent Years

open access: yesVaccines, 2022
Classical swine fever (CSF) is a severe disease that has caused serious economic losses for the global pig industry and is widely prevalent worldwide. In recent decades, CSF has been effectively controlled through compulsory vaccination with a live CSF ...
Fangfang Li   +10 more
doaj   +1 more source

DIFFERENTIATION BETWEEN VIRAL INFECTED AND VACCINATED CHICKEN BY USE OF TETANUS TOXOID AS AN EXOGENOUS MARKER [PDF]

open access: yesVeterinary Medical Journal - Giza, 2008
The present work was carried out to develop a simple and effective method for differentiating infected from vaccinated chickens to improve the control of infectious diseases.
AMANI A SALEH, ROUKAIA M OSMAN
doaj   +1 more source

A Recombinant Duck Plague Virus Containing the ICP27 Deletion Marker Provides Robust Protection in Ducks

open access: yesMicrobiology Spectrum, 2023
Duck plague virus (DPV) is a member of Alphaherpesvirus genus and poses a major threat to waterfowl breeding. Genetic engineered vaccines that are capable of distinguishing naturally infected from vaccine-immunized animals are useful for eradicating duck
Ying Wu   +19 more
doaj   +1 more source

The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal. [PDF]

open access: yes, 2014
Haemophilus influenzae type b (Hib) is now recognized as an important pathogen in Asia. To evaluate disease susceptibility, and as a marker of Hib transmission before routine immunization was introduced in Kathmandu, 71 participants aged 7 months-77 ...
Neelam Adhikari   +43 more
core   +2 more sources

Home - About - Disclaimer - Privacy